-
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial.
-
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I.
-
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms,
-
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
Patients presenting with acute coronary syndromes (ACS) should be administered dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel. However, some patients are subsequently found to have left main (LM) or multivessel disease (MVD) and require coronary artery bypass graft (CABG) surgery. For patients who have been loaded with clopidogrel, early CABG can result in excess bleeding:
-
Atrial septal defects (asd) are the most frequent congenital heart defects. Closure of the defect (either surgically or percutaneously) is a Class 1 recommendation in the ACC/AHA guidelines for management of adults with congenital heart disease when there is right heart dilation.
-
In this paper, daccarett and colleagues from the University of Utah assessed the potential contribution of cardiac magnetic resonance imaging for detection of left atrial fibrosis to risk stratify patients for stroke with atrial fibrillation.
-
-
Mineralocorticoid receptor blockers have demonstrated improved survival in class III-IV heart-failure patients (spironolactone) and post-acute myocardial infarction patients with systolic dysfunction heart failure (eplerenone).
-
The randomized evaluation of long-term anticoagulation Therapy (RE-LY) trial was a study that compared two doses of a new direct-thrombin inhibitor, dabigatran, to warfarin for stroke prevention in patients with atrial fibrillation.
